Literature DB >> 19453074

Diffuse type advanced gastric cancer showing dismal prognosis is characterized by deeper invasion and emerging peritoneal cancer cell: the latest comparative study to intestinal advanced gastric cancer.

K Yamashita1, S Sakuramoto, N Katada, N Futawatari, H Moriya, K Hirai, S Kikuchi, M Watanabe.   

Abstract

BACKGROUND/AIMS: Diffuse type advanced gastric cancer (D-AGC) is highly malignant disorder with dismal prognosis, however the causative attribution explaining such malignancy remains fully unexplained as compared to intestinal type AGC (I-AGC).
METHODOLOGY: We examined the archive of 232 AGC with cytology test (CY) but no distant metastasis, who underwent gastrectomy in Kitasato University Hospital in order to reveal the prognostic significance of D-AGC in a multivariate approach.
RESULTS: D-AGC occupied 68% (157/232) among AGC, and showed poorer prognosis than I-AGC (p = 0.024). Multivariate prognostic analysis revealed that independent prognostic factors for AGC are CY (p < 0.0001), pN (p = 0.0068), pT (p = 0.015), and age (p = 0.012), and that histology was eliminated, suggesting that histology itself does not represent high malignancy within the identical stage. D-AGC was significantly associated with younger age (p = 0.018), female preponderance (p = 0.006), advanced pT (p = 0.0002), advanced pN (p = 0.016), and positive CY factors (p = 0.032), among which negative prognostic factors were pT, pN, and CY factors. Multivariate logistic regression analysis elucidated that both pT (serosal exposure, p = 0.013) and CY (p = 0.034) factors were finally remnant independent predictors for D-AGC among the 3 univariate negative prognostic factors, but that pN was not. Intriguingly, age could be an independent prognostic factor only in D-AGC.
CONCLUSION: Our research revealed for the first time that more dismal prognosis of D-AGC than I-AGC could be explained by propensity of deeper invasion and emerging peritoneal cancer cell, and histology itself did not have a prognostic value, hence indicating that present staging system works properly even in D-AGC as well as I-AGC. We must identify its molecular mechanism of both invasion and emerging peritoneal disease of D-AGC in order to improve the prognosis.

Entities:  

Mesh:

Year:  2009        PMID: 19453074

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  26 in total

1.  Newly emerging standard chemotherapies for gastric cancer and clinical potential in elderly patients.

Authors:  Shinichi Sakuramoto; Keishi Yamashita; Masahiko Watanabe
Journal:  World J Gastrointest Oncol       Date:  2009-10-15

2.  Lectin microarray technology identifies specific lectins related to lymph node metastasis of advanced gastric cancer.

Authors:  Keishi Yamashita; Atsushi Kuno; Atsushi Matsuda; Yuzuru Ikehata; Natsuya Katada; Jun Hirabayashi; Hisashi Narimatsu; Masahiko Watanabe
Journal:  Gastric Cancer       Date:  2015-04-04       Impact factor: 7.370

3.  Metastatic lymph node ratio and Lauren classification are independent prognostic markers for survival rates of patients with gastric cancer.

Authors:  Huan Wang; Xiao-Ming Xing; Lei-Na Ma; Lian Liu; Jing Hao; Ling-Xin Feng; Zhuang Yu
Journal:  Oncol Lett       Date:  2018-04-13       Impact factor: 2.967

Review 4.  How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer.

Authors:  Christina Kim; Karen Mulder; Jennifer Spratlin
Journal:  Oncologist       Date:  2014-08-20

5.  Long-term prognostic outcome of cT1 gastric cancer patients who underwent laparoscopic gastrectomy after 5-year follow-up.

Authors:  Keishi Yamashita; Kei Hosoda; Hiromitsu Moriya; Hiroaki Mieno; Natsuya Katada; Masahiko Watanabe
Journal:  Langenbecks Arch Surg       Date:  2016-03-19       Impact factor: 3.445

Review 6.  Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.

Authors:  Keishi Yamashita; Shinichi Sakuramoto; Masahiko Watanabe
Journal:  Surg Today       Date:  2010-12-30       Impact factor: 2.549

Review 7.  Biomarkers for gastric cancer: prognostic, predictive or targets of therapy?

Authors:  Cecília Durães; Gabriela M Almeida; Raquel Seruca; Carla Oliveira; Fátima Carneiro
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

8.  Clinicopathologic characteristics and survival outcomes of patients with advanced esophageal, gastroesophageal junction, and gastric adenocarcinoma: a single-institution experience.

Authors:  A Dechaphunkul; K Mulder; F El-Gehani; S Ghosh; J Deschenes; J Spratlin
Journal:  Curr Oncol       Date:  2012-12       Impact factor: 3.677

9.  GEFT protein expression in digestive tract malignant tumors and its clinical significance.

Authors:  Yuanyuan Wang; Bing Zhang; Ge Gao; Yinping Zhang; Qingxin Xia
Journal:  Oncol Lett       Date:  2019-09-24       Impact factor: 2.967

10.  Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China.

Authors:  Miao-zhen Qiu; Mu-yan Cai; Dong-sheng Zhang; Zhi-qiang Wang; De-shen Wang; Yu-hong Li; Rui-hua Xu
Journal:  J Transl Med       Date:  2013-03-06       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.